Compare IQV & FTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IQV | FTI |
|---|---|---|
| Founded | 1982 | 1884 |
| Country | United States | United States |
| Employees | 93000 | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.1B | 29.1B |
| IPO Year | 2013 | 2016 |
| Metric | IQV | FTI |
|---|---|---|
| Price | $262.33 | $76.82 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 13 |
| Target Price | ★ $227.13 | $65.50 |
| AVG Volume (30 Days) | 1.2M | ★ 2.8M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.26% |
| EPS Growth | 4.67 | ★ 20.42 |
| EPS | ★ 1.61 | 1.53 |
| Revenue | $9,739,000,000.00 | ★ $9,932,600,000.00 |
| Revenue This Year | $6.77 | $8.49 |
| Revenue Next Year | $5.89 | $5.53 |
| P/E Ratio | $162.43 | ★ $49.61 |
| Revenue Growth | ★ 41.60 | 9.35 |
| 52 Week Low | $154.50 | $35.29 |
| 52 Week High | $262.51 | $80.55 |
| Indicator | IQV | FTI |
|---|---|---|
| Relative Strength Index (RSI) | 73.47 | 57.77 |
| Support Level | $159.91 | $66.61 |
| Resistance Level | N/A | $80.55 |
| Average True Range (ATR) | 7.47 | 2.48 |
| MACD | 0.69 | -0.10 |
| Stochastic Oscillator | 92.06 | 68.26 |
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
TechnipFMC PLC is the key provider of offshore oilfield services, offering integrated deep-water offshore oil and gas development solutions that span the full spectrum of subsea equipment and subsea construction services. The company also provides various pieces of surface equipment used with onshore oil and gas wells. TechnipFMC originated with the 2017 merger of Technip and FMC Technologies. Geographically it operates in Latin America generating the maximum revenue, then Europe and Central Asia, Africa, North America, Asia Pacific and Middle East.